Literature DB >> 26176500

The Evolution of Post-Traumatic Stress Disorder following Moderate-to-Severe Traumatic Brain Injury.

Yvette Alway1,2, Kate Rachel Gould1,2,3, Adam McKay1,2, Lisa Johnston2, Jennie Ponsford1,2,3.   

Abstract

Increasing evidence indicates that post-traumatic stress disorder (PTSD) may develop following traumatic brain injury (TBI), despite most patients having no conscious memory of their accident. This prospective study examined the frequency, timing of onset, symptom profile, and trajectory of PTSD and its psychiatric comorbidities during the first 4 years following moderate-to-severe TBI. Participants were 85 individuals (78.8% male) with moderate or severe TBI recruited following admission to acute rehabilitation between 2005 and 2010. Using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Disorders (SCID-I), participants were evaluated for pre- and post-injury PTSD soon after injury and reassessed at 6 months, 12 months, 2 years, 3 years, and 4 years post-injury. Over the first 4 years post-injury, 17.6% developed injury-related PTSD, none of whom had PTSD prior to injury. PTSD onset peaked between 6 and 12 months post-injury. The majority of PTSD cases (66.7%) had a delayed-onset, which for a third was preceded by subsyndromal symptoms in the first 6 months post-injury. PTSD frequency increased over the first year post-injury, remained stable during the second year, and gradually declined thereafter. The majority of subjects with PTSD experienced a chronic symptom course and all developed one or more than one comorbid psychiatric disorder, with mood, other anxiety, and substance-use disorders being the most common. Despite event-related amnesia, post-traumatic stress symptoms, including vivid re-experiencing phenomena, may develop following moderate-to-severe TBI. Onset is typically delayed and symptoms may persist for several years post-injury.

Entities:  

Keywords:  anxiety disorder; post-traumatic stress disorder; psychiatric disorder; traumatic brain injury

Mesh:

Year:  2015        PMID: 26176500     DOI: 10.1089/neu.2015.3992

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

1.  Frontal Traumatic Brain Injury Increases Impulsive Decision Making in Rats: A Potential Role for the Inflammatory Cytokine Interleukin-12.

Authors:  Cole Vonder Haar; Kris M Martens; Lara-Kirstie Riparip; Susanna Rosi; Cheryl L Wellington; Catharine A Winstanley
Journal:  J Neurotrauma       Date:  2017-05-24       Impact factor: 5.269

2.  Post-Traumatic Stress Disorder after Civilian Traumatic Brain Injury: A Systematic Review and Meta-Analysis of Prevalence Rates.

Authors:  Dominique L G Van Praag; Maryse C Cnossen; Suzanne Polinder; Lindsay Wilson; Andrew I R Maas
Journal:  J Neurotrauma       Date:  2019-08-02       Impact factor: 5.269

3.  Preliminary validation of the Dutch version of the Posttraumatic stress disorder checklist for DSM-5 (PCL-5) after traumatic brain injury in a civilian population.

Authors:  Dominique L G Van Praag; Haghish Ebad Fardzadeh; Amra Covic; Andrew I R Maas; Nicole von Steinbüchel
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

Review 4.  Neuroimaging Biomarkers of New-Onset Psychiatric Disorders Following Traumatic Brain Injury.

Authors:  Andrew R Mayer; Davin K Quinn
Journal:  Biol Psychiatry       Date:  2021-06-12       Impact factor: 13.382

5.  Chronic unpredictable stress during adolescence protects against adult traumatic brain injury-induced affective and cognitive deficits.

Authors:  Patricia B de la Tremblaye; JoDy L Wellcome; Kaitlyn Wiley; Carolyn A Lomahan; Eleni H Moschonas; Jeffrey P Cheng; Corina O Bondi; Anthony E Kline
Journal:  Brain Res       Date:  2021-06-04       Impact factor: 3.610

6.  Neurobiological mechanisms underlying delayed expression of posttraumatic stress disorder: A scoping review.

Authors:  Geert E Smid; Jonna Lind; Jens Peter Bonde
Journal:  World J Psychiatry       Date:  2022-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.